Dados B3 › BLAU3 × FLRY3 · Português

BLAU3 × FLRY3

BLAU3

BLAU FARMACÊUTICA S.A.
Saúde

9 restated figures

FLRY3

FLEURY SA
Saúde

18 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorBLAU3FLRY3year
ROE13.3%11.9%2025
ROIC12.2%11.6%2025
ROA8.4%4.5%2025
Gross margin40.1%26.6%2025
EBIT margin20.8%14.7%2025
Net margin17.4%7.2%2025
Net debt/EBITDA-0.04x1.47x2025
Current ratio2.47x1.97x2025
Revenue growth (1y)-3.0%7.9%2025
Revenue growth (5y CAGR)7.6%22.8%2025
Piotroski F-Score5/96/92025

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorBLAU3FLRY3year
P/E10.18x14.26x2025
P/B1.32x1.75x2025
EV/EBITDA7.05x5.58x2025
FCF yield-4.3%18.6%2025

BLAU3 · FLRY3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:46 UTC. If this does not match /saude, you are reading a cached copy.

Home · Methodology · Transparency · Audit it